CD30 Ligand
TNFSF8proteinCD30 ligand promotes leukocyte activation and vascular inflammation in the atherosclerotic plaque.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleTNF family member; CSF protein promoting immune activation.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000106952
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Identifying potential drug targets for myocardial infarction through Mendelian randomization.PloS one · 2024 · PMID 39715222 · doi